𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Genetic polymorphism of the CYP2E1 gene and susceptibility to Parkinson's disease in Taiwanese

✍ Scribed by R. M. Wu; C. W. Cheng; K. H. Chen; D. E. Shan; J. W. Kuo; Y. F. Ho; H. D. Chern

Publisher
Springer
Year
2002
Tongue
English
Weight
129 KB
Volume
109
Category
Article
ISSN
1435-1463

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Role of NQO1, MPO and CYP2E1 genetic pol
Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia
✍ Maja Krajinovic; Hugues Sinnett; Chantal Richer; Damian Labuda; Daniel Sinnett πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 124 KB

## Abstract Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer. The genetic factors underlying the susceptibility to this disease remain elusive. The enzymes CYP2E1, MPO and NQO1 are involved in the biotransformation of a variety of xenobiotics present in organic solvents, tobac

Association between dopamine transporter
Association between dopamine transporter gene polymorphism and susceptibility to Parkinson's disease in Japan
✍ Masataka Nishimura; Ryuji Kaji; Mitsuhiro Ohta; Ikuko Mizuta; Sadako Kuno πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 305 KB

We studied a polymorphism in the dopamine transporter (DAT) gene in 236 Japanese patients with Parkinson's disease (PD) and compared the results with 220 controls. The 1215A/G genotype of the DAT gene was significantly different between PD patients and controls, suggesting a possible involvement of

Interaction of polymorphisms in the gene
Interaction of polymorphisms in the genes encoding interleukin-6 and estrogen receptor beta on the susceptibility to Parkinson's disease
✍ Anna HΓ₯kansson; Lars Westberg; Staffan Nilsson; Silvia Buervenich; Andrea Carmin πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 68 KB πŸ‘ 2 views

## Abstract The multifunctional cytokine interleukin‐6 (IL‐6) is involved in inflammatory processes in the central nervous system and increased levels of IL‐6 have been found in patients with Parkinson's disease (PD). It is known that estrogen inhibits the production of IL‐6, via action on estrogen